Stem Cell Assays Market
Number of pages: 100 | Report Format: PDF | Published date: April 06, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 1.7 billion |
|
Revenue Forecast in 2031 |
US$ 7.3 billion |
|
CAGR |
17.3% |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Type, Product, Application, Cell Type, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global stem cell assays market was valued at US$ 1.7 billion in 2022 and is expected to register a revenue CAGR of 17.3% to reach US$ 7.3 billion by 2031.
Stem Cell Assays Market Fundamentals
Stem cell assays are laboratory methods used to identify and quantify stem cell properties, such as their ability to differentiate into different cell types and self-renew. These tests are critical for helping to understand stem cells and developing novel treatments for various diseases. Creating novel stem cell assay methods, such as 3-D cell culture and organoids, expanded the scope of stem cell applications. Innovative stem cell assays are now even more necessary to comprehend the stem cell activity and characteristics resulting from this. The market is also expected to expand due to the rising demand for stem cell-based therapies. The need for stem cell therapy is growing due to a rise in chronic diseases like cancer, diabetes, multiple myeloma, leukemia, Alzheimer's, and Parkinson's. Because stem cells can replenish themselves, they are ideal for drug discovery, diagnosis, and strategic treatment.
[76666]
Stem Cell Assays Market Dynamics
Stem cell research funding has grown over the past few years due to the rising demand for innovative therapeutics for patients suffering from cardiovascular, neurological, and immunological issues. Stem cell research has shown great potential in regenerative medicine for replacing or repairing damaged tissues and organs. Private businesses and charitable foundations have also made significant contributions to the endowment for stem cell research, many of which have started their research facilities and projects. Stem cell assays and appropriate characterizations are essential for stem cell research. The identification and separation of stem cells from other cell types using these tests is essential for the creation of stem cell treatments.
Additionally, stem cell research holds the promise of treating a variety of conditions, such as spinal cord injuries, Parkinson's disease, and Alzheimer's. Therefore, the additional funding from governments is a move in the right direction for advancing medical advancements and enhancing patient outcomes. Most patients can resume their normal activities after a stem cell procedure, which is an outpatient procedure. As the use of genetic data in clinical decision-making may increase as a result of new technology, advancing cancer patient prevention, surveillance, and safer, more effective pharmacological therapy, the demand for personalized medicine is also expected to rise, serving as another significant stem cell market revenue.
However, intense political and social arguments are also sparked by stem cell research. In generating pluripotent stem cell lines from oocytes and embryos, there are differences of opinion regarding the moment at which human personhood starts. Research on the therapeutic potential of embryonic stem cells is connected to several ethical conundrums, including the murder of human fetuses. The lack of appropriate laws may restrict the development of therapies using embryo-based stem cells in the future.
Therefore, difficult ethical dilemmas can emerge in any stem cell research regarding sensitive downstream research of stem cell assays, permission to donate resources for stem cell assays, early clinical studies of embryonic stem cell medicines, and oversight of human embryonic stem cell research. Likewise, a growing number of stem cell clinics are taking advantage of the interest in stem cells and operating outside the law by deceitfully pitching illegal and possibly dangerous products to people seeking medical treatment for ailments. Moreover, over 700 stem cell clinics operate in the United States alone, in addition to a sizable number in Latin America, Europe, Asia, and other places. These clinics frequently promote untested, risky, and possibly harmful products to patients who are afflicted with severe illnesses.
Stem Cell Assays Market Ecosystem
The global stem cell assay market is analyzed from six perspectives: type, product, application, cell type, end user, and region.
Stem Cell Assays Market by Type
Based on the types, the global stem cell assays market is segmented into viability/cytotoxicity assays, isolation & purification assays, cell identification assays, proliferation assays, differentiation assays, function assays, and apoptosis assays. The viability/cytotoxicity assays segment is further categorized into tetrazolium reduction assays, resazurin cell viability assays, and Calcein-AM cell viability assays. Also, the apoptosis assays segment is further classified into caspase assays, annexin v and cell permeability assays, DNA fragmentation assays, and mitochondrial assays.
The viability/cytotoxicity assays segment accounted for the largest revenue share of the global stem cell assays market in 2022. To ensure the success of the stem cell assays, it is essential to ensure the viability and regenerative capacity of the cells used in stem cell assays. One of the most crucial objectives of the quality control procedure for cells used in creating artificial organs is the assessment of cell viability. A better choice of the best cell sources would result from knowing the particular cell death mechanisms that may take place during sequential cell culturing. Additionally, creating non-invasive imaging methods and biomarkers to assess cell viability in vivo may yield useful data for adjusting the timing and dosage of cell-based treatments. Overall, regenerative medicine and tissue engineering development depend on a thorough strategy to evaluate cell viability and proliferation.
Cytotoxicity and cell viability tests quantify cellular or metabolic alterations brought on by viable or nonviable cells. The luminescent cell viability assay quantifies intracellular ATP and is the industry standard and the most accurate cell viability assay. These stem cell assays provide rapid cell lysis, ATPase inhibitors, and components for the luciferase response. The tetrazolium reduction assay, which gauges mitochondrial activity, and the trypan blue exclusion assay, which differentiates between alive and dead cells based on membrane permeability, are frequently used assays for cell viability.
Stem Cell Assays Market by Product
[71234]
Based on the products, the global stem cell assays market is segmented into instruments, kits, and services.
The instrument section is further sub-segmented into flow cytometers, microelectrode arrays, cell imaging and analysis system, and automated cell counters.
The instruments segment accounted for the largest revenue share of the global stem cell assays market in 2022. The phenotype of stem cell assays has become more significant due to flow cytometry developments. Due to their great potential in tissue engineering and regenerative medicine, stem cells have been isolated and characterized using new assays developed using these instruments. Additionally, stem cell differentiation into particular cell types can be observed using flow cytometry, giving researchers insight into the mechanisms underpinning this process.
Stem Cell Assays Market by Application
Based on the applications, the global stem cell assay market is segmented into regenerative medicine and therapy development, drug delivery and development, and clinical research.
The regenerative medicine and therapy development segment accounted for the largest revenue share of the global stem cell assay market. It is expected that advances in stem cell research will speed up the creation of novel products and spur the stem cell assays market for regenerative medicine and therapy development. Cord blood, adult, and embryonic stem cells are among the sources of stem cells that can stimulate the development of regenerative medicine. The commercialization of stem cells assays in tissue engineering and regenerative medicine development has been driven by the growing need for novel stem cells therapeutics. The adoption of regenerative medicine and organ transplantation has increased due to an increase in the frequency of trauma accidents. The market for stem cell assays has been stimulated by an increase in the frequency of mishaps, burn injuries, and other trauma. Several businesses have strengthened their position in the stem cell-focused field of regenerative medicine. However, the regenerative medicine sector is expected to expand quickly during the forecast period as the technologies for accidental care units are expected to advance.
Stem Cell Assays Market by Cell Type
Based on the cell types, the global stem cell assays market is segmented into adult stem cells and human embryonic stem cells. The adult stem cells market is segmented into mesenchymal stem cells, induced pluripotent stem cells, and hematopoietic stem cells.
Adult stem cells accounted for the largest revenue share of the global stem cell assays market. It is considered that adult stem cells have a lower likelihood of being rejected when used in transplants. This is due to the fact that they originate from the patient's body, which lowers the possibility of immunological rejection. Leukemia and spinal cord injuries are just two of the ailments and accidents that adult stem cells have shown promise in treating. Success has already been proven in a number of therapeutic settings. Adult stem cells can be removed from bone marrow, adipose, or blood with little negative impact on the donor. As per studies, they may be used to treat conditions like heart disease, Parkinson's disease, and spinal cord injuries. They have the capacity to differentiate into pluripotent stem cells, which enables them to have the benefits of embryonic cells without requiring the destruction of human fetuses.
Stem Cell Assays Market by End User
Based on the end users, the global stem cell assays market is segmented into biopharmaceutical & biotechnology companies, academic and research institutes, and others.
The biopharmaceutical & biotechnology companies segment accounted for the largest revenue share of the global stem cell assays market in 2022. Biopharmaceutical firms greatly aid the development and marketing of stem cell products. These businesses combine their knowledge of biology, medicine, and tech to develop safe, efficient treatments that can enhance patients' quality of life. These firms concentrate on developing new drugs and meeting the rising demand for stem cell-based treatments. In the process of finding new drugs, stem cell assays are an essential instrument that can screen a large number of substances. Drug discovery could be revolutionized by stem cell assays, resulting in the creation of more individualized and efficient treatments. In the upcoming years, the stem cell assay market is expected to maintain its revenue growth trajectory due to continuing research and developments in stem cell technology.
Stem Cell Assays Market by Region
Based on the region, the global Stem Cell Assays market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounted for the largest revenue share of the global Stem Cell Assays market in 2022. as businesses and academic institutions develop innovative therapies that are expected to take the place of embryonic stem cells in a number of contexts. Additionally, the market is expected to grow due to emerging technologies, the emphasis on stem cells, and technological advancement for tissue and organ transplantation. The U.S. has contributed the most to the market development, followed by Canada as a productive location.
Competitive Landscape of the Global Stem Cell Assays Market
In the upcoming years, the market for stem cells assays is expected to grow significantly as a result of initiatives by the government and the participation of major market participants. Prominent stakeholders, including international study & medical institutes, scientists, and researchers, are increasingly concentrating on coordinated efforts to provide more effective therapy options for life-threatening conditions. During the forecast period, it is expected that these cooperative efforts will considerably stimulate the market for stem cell assays. Notable market participants operating in the global stem cell assays market include:
Strategic Developments in Stem Cell Assays Market
Stem cells assays are performed to assess the potential in vivo invasive capacity of a stem-cell preparation.
The viability/cytotoxicity assays accounted for the highest revenue share of the global stem cell assays market.
Frequent errors and lack of proper handling are the key factors restricting the revenue growth of the global stem cell assays market.
Key companies operating the global stem cell assays market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Becton, Dickinson and Company, and Bio-Rad Laboratories.
The global stem cell assays market is expected to grow at a revenue CAGR of 17.3% during the forecast period from 2023 to 2031.
*Insights on financial performance are subject to the availability of information in the public domain